🔎 Trials Near Me

Hem › Neuroblastom › New York › New York City

Kliniska studier för Neuroblastom i New York City, NY

10 studier för Neuroblastom söker deltagare vid platser i och runt New York City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

RekryterarObservationsstudie
  • Memorial Sloan Kettering Cancer Center, New York
Alla åldrar · Alla kön · Uppdaterad 5 okt. 2026 · NCT00588068

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RekryterarFas 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Upp till ålder 30 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06172296

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

RekryterarFas 2Friska volontärer välkomna
  • Memorial Sloan Kettering Cancer Center, New York
Alla åldrar · Alla kön · Uppdaterad 30 sep. 2026 · NCT04936529

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RekryterarFas 1/2
  • Memorial Sloan Kettering Cancer Center ( Site 1010), New York
6 Months – 25 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT06395103

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

RekryterarFas 2
  • Memorial Sloan Kettering Cancer Center, New York
18 Months – 19 Years · Alla kön · Uppdaterad 28 aug. 2026 · NCT06528496

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RekryterarFas 3
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
365 Days – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekryterarFas 1/2
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

RekryterarFas 1/2
  • Memorial Sloan Kettering Kids, New York
Ålder 2 till 21 · Alla kön · Uppdaterad 11 aug. 2026 · NCT05642455

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

RekryterarFas 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Alla åldrar · Alla kön · Uppdaterad 28 juli 2026 · NCT06057948

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

RekryterarFas 2
  • Memorial Sloan Kettering Cancer Center, New York
Ålder 1 och äldre · Alla kön · Uppdaterad 29 maj 2026 · NCT00107289

Neuroblastom-studier i andra städer

Andra studier i New York City

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.